We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis. This possible complication has never been previously reported and, since our patient had a history of porphyria, it suggests that bisphosphonates should be administered cautiously in patients with this disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF02238770 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!